Supernus Pharmaceuticals | Stammkapital



Ordinary Share Capital Veränderung Datum
Abbott USD 25.12B 28M 2025-03
ANI Pharmaceuticals USD 2K 0 2024-12
Aurora Cannabis CAD 6.98B 907K 2024-12
Bristol-Myers Squibb USD 292M 0 2025-03
Canopy Growth CAD 8.67B 179.82M 2024-12
Corcept Therapeutics USD 136K 1000 2024-12
Eisai JPY 44.99B 0 2024-12
Eli Lilly USD 592.6M 200K 2025-03
Indivior 62M 0 2025-03
Novo Nordisk 446M 0 2024-09
Pacira USD 47K 0 2024-12
Perrigo USD 6.73B 30M 2024-12
Pfizer USD 481M 1000K 2025-03
Supernus Pharmaceuticals USD 56K 1000 2024-12
United Therapeutics USD 800K 0 2025-03
Xeris Pharmaceuticals USD 15K 0 2024-12



Supernus Pharmaceuticals Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.